Clinical trial
Duration of Skin Numbing Effect Created by the S-Caine™ Peel
NCT00110253 · ZARS Pharma Inc., Industry · Completed
Key facts
| NCT number | NCT00110253 |
|---|---|
| Title | Duration of Skin Numbing Effect Created by the S-Caine™ Peel |
| Official title | A Randomized, Double-Blind, Paired, Placebo Controlled Study Evaluating the Duration of Anesthetic Effect Produced by the S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) When Applied for 30 and 60 Minutes |
| Lead sponsor | ZARS Pharma Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%) |
| Enrollment | 40 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | May 5, 2005 |
| Last update posted | Jun 5, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: